Is there a role for glucagon-like peptide-1 receptor agonists in the management of diabetic nephropathy?

Chronic kidney disease constitutes a major microvascular complication of diabetes mellitus. Accumulating data suggest that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) might have a role in the management of diabetic kidney disease (DKD). GLP-1 RAs appear to reduce the incidence of persisten...

Descripción completa

Detalles Bibliográficos
Autores principales: Veneti, Stavroula, Tziomalos, Konstantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503505/
https://www.ncbi.nlm.nih.gov/pubmed/32994865
http://dx.doi.org/10.4239/wjd.v11.i9.370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503505/
https://www.ncbi.nlm.nih.gov/pubmed/32994865
http://dx.doi.org/10.4239/wjd.v11.i9.370

Ejemplares similares